The PATHWAY HER2 (4B5) test is now FDA-approved to assess HER2-ultralow status in metastatic breast cancer, expanding its ...
The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...
As monotherapy for treatment of adult patients with advanced NSCLC with activating EGFR exon 20 insertion mutations, after failure of platinum-based therapy.
Roche has announced that the FDA has expanded the approval of its PATHWAY® HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test to identify HE ...
As seen in the DESTINY-Breast06 trial, a pproximately 20-25 percent of hormone receptor (HR)-positive, HER2- ...
Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous ...
The first advance estimate of India’s Gross Domestic Product (GDP) in 2024-25, released by the National Statistics Office (NSO) this week, shows a decline in the real GDP growth rate to 6.4% ...
The UK economy returned to growth for the first time in three months, but the expansion was less than expected. The 0.1% uptick in November was driven by trade for pubs, restaurants and the ...
"Interestingly, precisely this pathway of cGMP formation has long been known in biochemistry and medicine as a promoter of bone growth," says study leader Robert Feil. Genetic variants of the ...
Université de Bourgogne, U1231 INSERM, CTM, Equipe DesCarTes, UFR Sciences de Santé, 7 Bd Jeanne d’Arc, 21078 Dijon Cedex, France ...
In a world filled with uncertainty, hope provides a pathway to resilience and growth. By focusing on future possibilities, setting meaningful goals, and believing in the capacity to achieve them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback